Angioimmunoblastic T-Cell Lymphoma Refractory
2 clinical trials · Condition
◉ Watch Angioimmunoblastic T-Cell Lymphoma Refractory
| Record | Firm | Date |
|---|---|---|
| Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms (NCT03493451) | BeiGene | 2018-04-13 |
Track Angioimmunoblastic T-Cell Lymphoma Refractory automatically
Every clearance here is in the API, with alerts when new ones post.